Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Alexandra Sakatos
AddedFeb 16, 2024
UpdatedMay 31, 2026
Alexandra Sakatos

Alexandra Sakatos

Co-Founder, Deep Science Ventures

CrunchbaseLinkedInThe Org

Alexandra Sakatos's Career

Deep Science Ventures
Deep Science Ventures

London, Greater London, GB

Co-Founder
Ancilia Biosciences
Ancilia Biosciences

New York City, NY, US

Co-Founder

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Alexandra Sakatos's Career

Deep Science Ventures
Deep Science Ventures
Investment Firm612016London, Greater London, GB
Co-Founder

Leadership at Deep Science Ventures

Sina AtashpazSina AtashpazCo-Founder
Elisa ArthoferElisa ArthoferCo-Founder
Dominic FalcãoDominic FalcãoCo-Founder
Steffen GeorgSteffen GeorgCo-Founder
Mauricio Herrera RodriguezMauricio Herrera RodriguezCo-Founder
Rubi SimhayovRubi SimhayovCo-Founder

Similar to Deep Science Ventures

Deep VenturesDeep VenturesSan Francisco, CA, USDeep VenturesSan Francisco, CA, US

Deep Ventures: An early-stage tech investment firm dedicated to empowering AI entrepreneurs.

6
Phystech VenturesPhystech VenturesLondon, Greater London, GBest. 2013Phystech VenturesLondon, Greater London, GB · est. 2013

PV: An early-stage deeptech venture capital firm, investing in computing, life sciences, energy, mobility, and space.

13
ScientificaScientificaRome, Province of Rome, ITest. 1996ScientificaRome, Province of Rome, IT · est. 1996

Scientifica VC: Investing in innovative startups and technologies for social and environmental impact.

25
Deep InsightDeep InsightHerzliya, Tel Aviv District, ILest. 2021Deep InsightHerzliya, Tel Aviv District, IL · est. 2021

Deep Insight: Israel's premier venture fund, investing in all stages of Deep Tech across sectors.

4
Ancilia Biosciences
Ancilia Biosciences
$1M62019New York City, NY, US
Co-Founder

Leadership at Ancilia Biosciences

Matthew CummingsMatthew CummingsCo-Founder

Similar to Ancilia Biosciences

Ancora BiotechAncora BiotechPalo Alto, CA, USAntibody Drugsest. 2021Ancora BiotechPalo Alto, CA, US · est. 2021

Biotech firm developing antibody drugs for B cell cancers, inflammatory disorders, and chronic hepatitis B.

$60M12
NexilicoNexilicoBerkeley, CA, USMicrobiomeest. 2019NexilicoBerkeley, CA, US · est. 2019

Nexilico, Inc.: An R&D startup advancing microbiome research and precision medicine through predictive computational platforms.

$2M4
NextbioticsNextbioticsSan Francisco, CA, USViral Engineeringest. 2017NextbioticsSan Francisco, CA, US · est. 2017

Nextbiotics: A biotech platform engineering viruses for beneficial purposes.

$750k7
Federation BioFederation BioSouth San Francisco, CA, USTreatmentsest. 2019Federation BioSouth San Francisco, CA, US · est. 2019

Federation Bio: Pioneering platforms for disease-targeting curative treatments via the human microbiome.

$50M46

People Similar to Alexandra Sakatos

Nugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakAchmad ZakyAchmad ZakyCo-Founder · BukalapakWillix HalimWillix HalimCEO · BukalapakChi-hyung SongChi-hyung SongCo-Founder · DunamuHaeil YiHaeil YiCo-Founder · DunamuLee Sirg-OoLee Sirg-OoCEO · DunamuHyoung-nyon KimHyoung-nyon KimCo-Founder · DunamuIn-hyuk ChoiIn-hyuk ChoiCEO · Naver FinancialSven KiliSven KiliCEO at Antion BiosciencesArjun GanesanArjun GanesanCo-Founder · AnceraEric GrosgogeatEric GrosgogeatBoard Member · SagoMark CisnerosMark CisnerosBoard Member · Amplified SciencesBill CortelyouBill CortelyouCEO · Phoseon TechnologyFrank L. JakschFrank L. JakschBoard Member · ChromaDex